MA
Veradermics, Incorporated
MANE · NYSE
$106.64 -1.88% (-$2.04)
1M +8.42%
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
59 /100
Moderate Beta 1.23x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MANE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Reid Waldman
Employees
37
Headquarters
New Haven
Upcoming events
10 NOV
Earnings
Upcoming earnings report